Cargando…
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial
BACKGROUND: Efficacy of live oral rotavirus vaccines is reduced in low-income compared with high-income settings. Parenteral non-replicating rotavirus vaccines might offer benefits over oral vaccines. We assessed the safety and immunogenicity of the P2-VP8-P[8] subunit rotavirus vaccine at different...
Autores principales: | Groome, Michelle J, Koen, Anthonet, Fix, Alan, Page, Nicola, Jose, Lisa, Madhi, Shabir A, McNeal, Monica, Dally, Len, Cho, Iksung, Power, Maureen, Flores, Jorge, Cryz, Stanley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771518/ https://www.ncbi.nlm.nih.gov/pubmed/28483414 http://dx.doi.org/10.1016/S1473-3099(17)30242-6 |
Ejemplares similares
-
Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial
por: Groome, Michelle J, et al.
Publicado: (2020) -
Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial
por: Fellows, Tamika, et al.
Publicado: (2023) -
Neutrophil Counts in Healthy South African Infants: Implications for Enrollment and Adverse Event Grading in Clinical Trials in an African Setting
por: Koen, Anthonet, et al.
Publicado: (2019) -
The Functional Characterization of Bat and Human P[3] Rotavirus VP8*s
por: Li, Dandi, et al.
Publicado: (2021) -
Glycan binding patterns of human rotavirus P[10] VP8* protein
por: Pang, Li-li, et al.
Publicado: (2018)